Navigation Links
PRA International to Present Audioconference on Oncology Research - Nov. 8
Date:10/23/2007

PRA Oncology Expert to Speak

RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (Nasdaq: PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic expertise and a specialist in oncology and hematology, will present a one-hour audioconference on conducting global clinical research in oncology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST. In "Challenges in Conducting Global Oncology Trials," Dr. Berger will recommend ways to mitigate risk in terms of timelines and costs.

The audioconference will be of special interest to leaders in pharmaceutical and biotechnology research and development, clinical development, operations, clinical studies, outsourcing, procurement, and global data management. The registration fee is US$199 per phone line. For more information and to register, go to http://www.fxtrans.com/resources/ac/future/ac20071108.htm.

The speaker earned her medical degree from Germany's University of Heidelberg where she has served in senior positions on the Faculty of Clinical Medicine for nearly 20 years. Dr. Berger holds medical certifications in internal medicine, oncology and hematology, and is certified by the European Society of Medical Oncology. She has held numerous high-visibility positions, including as medical coordinator for the German CML Study Group, general manager of the German Competence Network "Acute and Chronic Leukemias" and scientific network manager of the "European LeukemiaNet."

Dr. Berger has established relationships with key opinion leaders in the hematology/oncology field around the world. Widely published, she is known for her expertise in clinical research and has significant experience overseeing, directing and implementing global oncology trials in a variety of indications.

The audioconference is presented in cooperation with ForeignExchange Translations, Inc., the leader in providing linguistic services to medical device, pharmaceutical and biotech companies.

About PRA International

PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, Asia, South America, Africa and Australia. PRA is committed to delivering reliable service, program-level therapeutic expertise, easy, global access to knowledge and an involved senior management.

To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.


'/>"/>
SOURCE PRA International
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):